Stockmark.IT - Global News Affecting Stock Markets and Investments

Close-up of a person injecting a Wegovy 2.4 mg semaglutide pen into their abdomen. The hand holding the pen is visible as the injection is administered. The background shows bare skin, focusing on the injection process.

Novo Nordisk launches Wegovy pill in US market at significantly lower cost than injectable alternatives

Novo Nordisk has introduced the first oral formulation of its blockbuster GLP-1 weight loss medication to the United States market, marking a significant shift in the pharmaceutical landscape for obesity

A Marks & Spencers store with large glass windows and illuminated signage on a city street. People are walking on the pavement and shopping inside the brightly lit store.

Weightloss2 weeks ago

Marks and Spencer Launches Nutrient Dense Food Range Targeting Weight Loss Drug Users

Marks and Spencer has unveiled a specialised food range designed for consumers taking GLP-1 weight-loss medications, marking a significant retail adaptation to the pharmaceutical trend reshaping consumer behaviour across the

All posts tagged in GLP-1 medications

Novo Nordisk launches Wegovy pill in US market at significantly lower cost than injectable alternatives

Marks and Spencer Launches Nutrient Dense Food Range Targeting Weight Loss Drug Users

Recent Posts